Anna Protopapas
2020
Compensation breakdown
Non-Equity Incentive Plan | $324,500 |
---|---|
Option Awards | $1,220,079 |
Salary | $550,000 |
Stock Awards | $436,331 |
Other | $7,000 |
Total | $2,537,911 |
Protopapas received $1.2M in option awards, accounting for 48% of the total pay in 2020.
Protopapas also received $324.5K in non-equity incentive plan, $550K in salary, $436.3K in stock awards and $7K in other compensation.
Rankings
In 2020, Anna Protopapas' compensation ranked 4,481st out of 13,090 executives tracked by ExecPay. In other words, Protopapas earned more than 65.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,481 | 66th |
Manufacturing | 1,815 | 68th |
Chemicals And Allied Products | 703 | 69th |
Drugs | 602 | 69th |
Pharmaceutical Preparations | 457 | 69th |
Protopapas' colleagues
We found four more compensation records of executives who worked with Anna Protopapas at Mersana Therapeutics in 2020.
2020
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
2020
Timothy Lowinger
Mersana Therapeutics
Chief Science and Technology Officer
2020
Michael Kaufman
Mersana Therapeutics
Chief Manufacturing Officer
2020
Brian DeSchuytner
Mersana Therapeutics
Senior Vice President, Finance & Product Strategy
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021
April 20, 2020
April 23, 2019